Objective: Objective: Pulse wave velocity (PWV) analysis represents an important tool to identify subclinical hypertension-mediated organ damage and, carotid-femoral PWV is the gold standard method for measuring large artery stiffness. SAGE is a validated clinical score and it uses four clinical parameters (office SBP, Age, Fasting Glucose and eGFR categories) to identify hypertensive patients with high likelihood of nigh PWW and thus high risk of a major risk of cardiovascular events. We have applied this score to Latin American hypertensive patients evaluated with oscilometric devices. Design and method: Methods: A retrospective analysis of patients submitted to central blood pressure measurement using the validated oscilometric Mobil-O-Graphâ. We have then selected those with hypertension and with all the SAGE parameters available. The score was divided into 18 categories (0 to 17) and, to each of them, a PWV greater 10m/sec analysis of sensitivity, specificity, positive and negative predictive value was done. A ROC curve using Youden index was constructed to define better score to identify these patients with high risk for elevated PWV Results: Results: A total of 1266 patients were selected and 837 have reached predefined criteria of SAGE parameters. Mean age was 58 ± 15 years and 49,3% were male. Diabetes was found in 17% of the sample, smoking 18% and 582 (70%) patients were using anti-hypertensive drugs. Mean office blood pressure was 129 ± 18,2 mmHg for systolic and 82 ± 13,1 mmHg for diastolic. PWV median was 8,3 m/sec ± 2,1 m/sec. According to ROC curves a cut-off >7 was the best one to identify high risk of PWV greater 10 m/sec (sensibility 67,19% CI 95%: 60,1–73,8, specificity 93,95% CI 95%: 91,8–95,7). With this cut-off point 1 in each 5 hypertensive patients would be referred to PWV measurement. This value is close to one that the Original SAGE score identified (>8). Conclusions: Conclusion: SAGE score that identifies patients with high PWV is operational when applied to hypertensive Latin American population with oscilometric device measurement. Yielded cut-off values are similar to those in the original cohort that was validated with carotid-femoral PWV measurements in a European population.